Clinical Trials Browser

Phase 2 × Injections × CNS × Clear all

NCT06013618 2025-06-17

Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma

Phase 2 Recruiting

Neuroblastoma

NCT06598787 2025-05-07

A Study of BL-B01D1 in Patients With Recurrent Glioblastoma

Phase 2 Recruiting

Glioblastoma

NCT02584400 2019-03-08

HX4 SD

Phase 2 Terminated

CNSGastrointestinalGenitourinary

Hypoxia, Brain Neoplasms, Esophageal Neoplasms, Neoplasm Metastasis, Prostatic Neoplasms, Rectal Neoplasms